MRNA US60770K1079

Report

Real-time Estimate - 06/23 01:58:51 pm
220.1050	USD		-0.57%

07:18a

GSK's drugs arm to get $11 billion windfall from consumer spin-off

02:11a

Debate Intensifies Over A Vaccine IP Waiver's Impact On Future Pharma And Biotech Discoveries

01:02a

SECTORAL ASSET MANAGEMENT : Covid-Vaccine Patent Waiver: Will it Increase Worldwide Access?

Summary

Quotes 5-day view Delayed Quote.

Delayed Nasdaq

06/16/2021	06/17/2021	06/18/2021	06/21/2021	06/22/2021	Date
197.84(c)	202.47(c)	199.19(c)	208.24(c)	221.36(c)	Last
7 264 747	4 955 160	6 663 813	7 423 063	10 066 344	Volume
-1.86%	+2.34%	-1.62%	+4.54%	+6.30%	Change

More quotes

Estimated financial data (e) (USD)

Sales 2021	18 632 M - -
Net income 2021	10 719 M - -
Net cash position 2021	11 520 M - -
P/E ratio 2021	8,97x
Yield 2021	-

Sales 2022	15 883 M - -
Net income 2022	7 395 M - -
Net cash position 2022	20 906 M - -
P/E ratio 2022	12,5x
Yield 2022	-

Capitalization	88 882 M 88 882 M -
EV / Sales 2021	4,15x
EV / Sales 2022	4,28x
Nbr of Employees	1 300
Free-Float	90,3%

More Financials

Company

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows: - Collaboration revenue (79.8%); - Grant revenue (20.2%). At the end of 2019, the group possessed a portfolio of 6 development candidates in clinical studies, with three in phase II and...

Sector

Biotechnology & Medical Research

Calendar

08/11

Earnings Release

More about the company

Ratings of Moderna, Inc.

Trading Rating :

Investor Rating :

ESG Refinitiv :

C-

More Ratings

All news about MODERNA, INC.

07:18a	GSK's drugs arm to get $11 billion windfall from consumer spin-off	RE
02:11a	Debate Intensifies Over A Vaccine IP Waiver's Impact On Future Pharma And Bio..	AQ
01:02a	SECTORAL ASSET MANAGEMENT : Covid-Vaccine Patent Waiver: Will it Increase World..	DJ
06/22	MODERNA : B.C. health officials say mixing mRNA vaccines is safe, effective	AQ
06/22	Nasdaq hits record high as Big Tech roars back	RE
06/22	MODERNA : president talks COVID-19 and vaccine technology	AQ
06/22	MODERNA : European Commission Purchases Additional 150 Million Doses of Moderna..	BU
06/22	MODERNA : to Supply Additional 150 Million Doses of COVID-19 Vaccine to Europea..	MT
06/22	Today on Wall Street: The investor dilemma
06/22	MODERNA : Doctors Without Borders (MSF) responds to mRNA COVID vaccine technolo..	AQ
06/22	MODERNA : European Commission To Buy Additional 150 Million COVID-19 Vaccine Sh..	MT
06/22	MODERNA : Doctors Without Borders (MSF) responds to mRNA COVID vaccine technolo..	AQ
06/22	MARKET CHATTER : SK Bioscience to Invest $132 Million in Expansion of COVID-19 V..	MT
06/21	U.S. administers more than 318 mln doses of COVID-19 vaccines - CDC	RE
06/21	MODERNA : U.S. CDC Says Administered 318,576,441 Doses Of Covid-19 Vaccine As O..	RE

More news

News in other languages on MODERNA, INC.

06:25a	COVID : 15,3 mln dosi Pfizer e Moderna a giugno, 14,5 mln a luglio
01:02a	SECTORAL ASSET MANAGEMENT : Covid-Impfstoff-Patentverzicht - wird er den weltwe..
06/22	WALL STREET STOCK EXCHANGE : Wall Street finit en hausse, la "tech" porte le Nas..
06/22	CORONA-BLOG/USA werden 70-Prozent-Ziel bei Impfungen zum 4. Juli verpassen
06/22	CORONA-BLOG/EU-Kommission gibt Italien grünes Licht für massive Corona-Hilfen

More news

Analyst Recommendations on MODERNA, INC.

06/07	MODERNA : Piper Sandler Adjusts Moderna's Price Target to $246 From $231, Maint..	MT
05/07	MODERNA : Chardan Adjusts Price Target on Moderna to $188 From $182, Maintains ..	MT
05/07	MODERNA : JPMorgan Adjusts Moderna's Price Target to $127 From $121, Maintains ..	MT

More recommendations

Stock Trading Strategies

	MODERNA, INC. - 2020
The beginning of the move

BUY

More Stock Trading Analysis

Provided by Scoopnest.com

Analysis

Samsung BioLogics shares ease after jumping on vaccine deal